{"id":"https://openalex.org/W1982919970","doi":"https://doi.org/10.1002/chir.20356","title":"Stereoselective analysis of hydroxybupropion and application to drug interaction studies","display_name":"Stereoselective analysis of hydroxybupropion and application to drug interaction studies","alternate_titles":[],"publication_year":2006,"publication_date":"2006-12-13","ids":{"openalex":"https://openalex.org/W1982919970","doi":"https://doi.org/10.1002/chir.20356","mag":"1982919970","pmid":"https://pubmed.ncbi.nlm.nih.gov/17167747"},"language":"en","primary_location":{"id":"doi:10.1002/chir.20356","doi":"https://doi.org/10.1002/chir.20356","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.20356","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982919970"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068254469","display_name":"Hongmei Xu","orcid":"https://orcid.org/0000-0002-8650-8694","observed_orcids":["https://orcid.org/0000-0002-8650-8694","https://orcid.org/0000-0001-5787-4516","https://orcid.org/0009-0003-4412-6131"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Hongmei Xu","raw_affiliation_strings":["Faculty of Pharmacy, University of Sydney, Australia","Co-first authors"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, University of Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Co-first authors","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010753411","display_name":"Katarzyna K. Loboz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Katarzyna K. Loboz","raw_affiliation_strings":["Co-first authors","Faculty of Pharmacy, University of Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Co-first authors","institution_ids":[]},{"raw_affiliation_string":"Faculty of Pharmacy, University of Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056672566","display_name":"Annette S. Gross","orcid":"https://orcid.org/0000-0001-9567-0127","observed_orcids":["https://orcid.org/0000-0001-9567-0127"]},"institutions":[{"id":"https://openalex.org/I4210099246","display_name":"GlaxoSmithKline (Australia)","ror":"https://ror.org/0108bjm70","country_code":"AU","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210099246"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Annette S. Gross","raw_affiliation_strings":["Clinical Pharmacology and Discovery Medicine, GlaxoSmithKline Research and Development, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology and Discovery Medicine, GlaxoSmithKline Research and Development, Sydney, Australia","institution_ids":["https://openalex.org/I4210099246"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045823606","display_name":"Andrew J. McLachlan","orcid":"https://orcid.org/0000-0003-4674-0242","observed_orcids":["https://orcid.org/0000-0003-4674-0242"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800249840","display_name":"Concord Repatriation General Hospital","ror":"https://ror.org/04b0n4406","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800249840"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Andrew J. McLachlan","raw_affiliation_strings":["Centre for Education and Research on Ageing, Concord Hospital, Sydney, Australia","Faculty of Pharmacy, University of Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Education and Research on Ageing, Concord Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I2800249840"]},{"raw_affiliation_string":"Faculty of Pharmacy, University of Sydney, Australia","institution_ids":["https://openalex.org/I129604602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045823606"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800249840"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":1.1427,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.7061355,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"19","issue":"3","first_page":"163","last_page":"170"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0348999984562397,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.013500000350177288,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydroxybupropion","display_name":"hydroxybupropion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.859000027179718},{"id":"https://openalex.org/keywords/stereoselective-pharmacokinetics","display_name":"stereoselective pharmacokinetics","score":0.7940000295639038},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.7089999914169312},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.625},{"id":"https://openalex.org/keywords/enantiomeric-ratio","display_name":"enantiomeric ratio","score":0.6919999718666077},{"id":"https://openalex.org/keywords/plasma-quantitation","display_name":"plasma quantitation","score":0.6010000109672546},{"id":"https://openalex.org/keywords/hplc-analysis","display_name":"HPLC assay","score":0.6740000247955322},{"id":"https://openalex.org/keywords/liquid-liquid-extraction","display_name":"liquid-liquid extraction","score":0.7860000133514404},{"id":"https://openalex.org/keywords/phenacetin-internal-standard","display_name":"phenacetin internal standard","score":0.7110000252723694},{"id":"https://openalex.org/keywords/antidepressant-metabolites","display_name":"antidepressant metabolites","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7924007177352905},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7367749214172363},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.7060223817825317},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.6778854131698608},{"id":"https://openalex.org/C181647583","wikidata":"https://www.wikidata.org/wiki/Q903429","display_name":"Stereoselectivity","level":3,"score":0.6073816418647766},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.501349925994873},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.45065024495124817},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.34604668617248535},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.17301729321479797},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16727349162101746},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0791100263595581},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0749712586402893},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/chir.20356","doi":"https://doi.org/10.1002/chir.20356","is_oa":false,"landing_page_url":"https://doi.org/10.1002/chir.20356","pdf_url":null,"source":{"id":"https://openalex.org/S67976470","display_name":"Chirality","issn_l":"0899-0042","issn":["0899-0042","1520-636X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"journal-article"},{"id":"pmid:17167747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17167747","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chirality","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1912050742","https://openalex.org/W1966141246","https://openalex.org/W1971106062","https://openalex.org/W1978926017","https://openalex.org/W1995878239","https://openalex.org/W1997066747","https://openalex.org/W2004690865","https://openalex.org/W2021306862","https://openalex.org/W2024231181","https://openalex.org/W2035873213","https://openalex.org/W2053102419","https://openalex.org/W2073940796","https://openalex.org/W2077082917","https://openalex.org/W2084564882","https://openalex.org/W2084863149","https://openalex.org/W2089663335","https://openalex.org/W2108430406","https://openalex.org/W2110891284","https://openalex.org/W2113404595","https://openalex.org/W2116124049","https://openalex.org/W2119678057","https://openalex.org/W2142120450","https://openalex.org/W2143764289","https://openalex.org/W2157144772","https://openalex.org/W2327807854","https://openalex.org/W2334891622","https://openalex.org/W2340305300"],"related_works":["https://openalex.org/W2001259480","https://openalex.org/W2287948525","https://openalex.org/W2288953196","https://openalex.org/W2538426209","https://openalex.org/W2120488838","https://openalex.org/W2066572821","https://openalex.org/W2136903432","https://openalex.org/W2073940796","https://openalex.org/W2363723879","https://openalex.org/W2752652647"],"abstract_inverted_index":{"A":[0,162,208],"sensitive":[1],"and":[2,29,45,65,74,91,102,131,223],"stereoselective":[3,126,163],"assay":[4,25],"has":[5],"been":[6],"developed":[7],"for":[8,63,81,111],"the":[9,12,57,92,105,156,175,212,231,237],"quantitation":[10],"of":[11,14,19,60,88,108,116,119,128,146,165,177,187,234],"enantiomers":[13,90,121],"hydroxybupropion,":[15],"an":[16,228],"active":[17],"metabolite":[18],"bupropion,":[20],"in":[21,133,160,181,211,230],"human":[22],"plasma.":[23,161],"The":[24,52,67,114,125,185],"used":[26],"liquid-liquid":[27],"extraction":[28,86],"a":[30,37,143,182],"Cyclobond":[31],"I":[32],"2000":[33],"HPLC":[34],"column":[35],"with":[36,172,227],"mobile":[38],"phase":[39],"containing":[40],"3%":[41],"acetonitrile,":[42],"0.5%":[43],"triethylamine,":[44],"20":[46],"mM":[47],"ammonium":[48],"acetate":[49],"(pH":[50],"3.8).":[51],"technique":[53],"was":[54,69,98,122,155,170,216],"linear":[55],"over":[56,104,236],"concentration":[58,106],"range":[59,107],"12.5-500":[61,109],"ng/ml":[62,110],"(2R,3R)-":[64,130],"(2S,3S)-hydroxybupropion.":[66],"method":[68],"reproducible":[70,103],"as":[71],"both":[72,82,129,221],"interday":[73],"intraday":[75],"variabilities":[76],"were":[77,140],"less":[78],"than":[79,100],"10%":[80],"hydroxybupropion":[83,89,120,168,179,213],"enantiomers.":[84],"Overall":[85],"recovery":[87],"internal":[93],"standard":[94],"phenacetin":[95],"from":[96,194],"plasma":[97],"greater":[99],"80%":[101],"each":[112,178],"enantiomer.":[113],"limit":[115],"quantification":[117],"(LOQ)":[118],"12.5":[123],"ng/ml.":[124],"pharmacokinetics":[127,176],"(2S,3S)-hydroxybupropion":[132,191,235],"healthy":[134],"male":[135],"subjects":[136],"(n":[137],"=":[138],"16)":[139],"investigated":[141],"after":[142,218],"single":[144],"dose":[145],"(rac)-bupropion":[147,219],"either":[148],"alone":[149],"or":[150],"during":[151,202,224],"rifampicin":[152,166,173,203,225],"administration.":[153],"(2R,3R)-Hydroxybupropion":[154],"predominant":[157],"enantiomer":[158,180],"present":[159],"effect":[164],"on":[167],"concentrations":[169],"observed,":[171],"influencing":[174],"different":[183],"manner.":[184],"ratio":[186,215],"(2R,3R)-hydroxybupropion":[188],"(AUC(0-24))":[189,192],"to":[190,198],"increased":[193],"4.9":[195],"+/-":[196,200],"1.6":[197],"8.3":[199],"1.9":[201],"administration":[204,220],"(P":[205],"<":[206],"0.001).":[207],"time-dependent":[209],"change":[210],"enantiomeric":[214],"observed":[217],"before":[222],"coadministration,":[226],"increase":[229],"relative":[232],"proportion":[233],"24":[238],"h":[239],"postdose":[240],"period.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982919970","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
